Under construction – not a live service
Sign in
Not yet taking people in RussiaPhase 3

Checking bowel blood flow with a glowing dye during colorectal cancer surgery

Tests glowing dye imaging to prevent bowel leaks after colorectal cancer surgery.

Plain-language title generated from the registry record
Registry title: The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage in Colorectal Surgery

Key facts

Where
Vsevolozhsk District, RussiaSee the site
Phase
Phase 3

Where in Russia

  • BELOOSTROV Clinic of High TechnologiesVsevolozhsk District, RussiaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Vadim Kuznetsov
Trial code
NCT06845306
Record updated
25 February 2025
Original description
Anastomotic leakage (AL) is a serious complication after surgery for colon cancer, leading to a significant increase in mortality.Intraoperative fluorescence imaging using indocyanine green has proven to be a feasible and reproducible technique for real-time perfusion assessment.Read full original descriptionShow less

Indocyanine Green Near-infrared Fluorescence Bowel Perfusion Quantitative Assessment to Prevent Anastomotic Leakage in Colorectal Surgery: a Multicentre, Randomised, Controlled Study

Anastomotic leakage (AL) is a serious complication after surgery for colon cancer, leading to a significant increase in mortality.Intraoperative fluorescence imaging using indocyanine green has proven to be a feasible and reproducible technique for real-time perfusion assessment.

An increasing number of studies are being published on the use of indocyanine green (ICG) fluorescence imaging in colorectal cancer surgery, showing promising results.

Therefore, we propose conducting a multicenter, randomized controlled trial to investigate the potential use of quantitative assessment of near-infrared fluorescence imaging with indocyanine green (ICG) to prevent anastomotic leaks during colorectal surgery.

Inclusion: Patients aged over 18 years old; ECOG status 0-2; Written informed consent; histologically confirmed neoplasms malignant of the colon (caecum, ascending, transverse, descending, sigmoid); Scheduled for colorectal resection with primary anastomosis.

Exclusion: Medical contraindications for surgical treatment; Colon obstruction, perforation or bleeding complicating the tumor; Known allergy or history of adverse reaction to ICG, iodine or iodine dyes; Pregnancy or breast feeding.

ClinicalTrials.gov NCT06845306